The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Opinions expressed by Forbes Contributors are their own. Hugh McIntyre covers music, with a focus on the global charts. Lynyrd Skynyrd still commands a massive fan base in the U.S. to this day.